sales

Showing 15 posts of 91 posts found.

Lilly building

Eli Lilly predicts revenue growth in 2016

January 5, 2016
Research and Development, Sales and Marketing Eli Lilly, financial reports, marketing, sales

Eli Lilly has set out its financial guidance for 2016, predicting an increase in sales to between $20.2 and $20.7 …

Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015
Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …

580x381_merck_opens_its_office_in_nigeria_3_tcm2432_145041

Merck on the march in Africa

December 21, 2015
Sales and Marketing Africa, Merck, marketing, sales, strategy

When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …

Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015
Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …

anastrazole

Pharma company vows to plough profits back into R&D

November 30, 2015
Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise

An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …

dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015
Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …

Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Sanofi reception

Brandicourt set to continue Sanofi restructure

September 28, 2015
Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off

Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …

Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015
Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …

GSK image

GSK blames respiratory woes as sales drop

February 5, 2015
Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales

GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …

Lilly image

Lacklustre sales hit Lilly again

October 24, 2014
Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

Sales image

The end of salesmanship?

August 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship

Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …

gsk image

Another major drop in sales for GSK

July 23, 2014
Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

Merck image

Merck’s Q1 sales drop

April 30, 2014
Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales

Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …

gsk image

GSK China rep speaks out over ‘bribery culture’

April 2, 2014
Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales

A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …

The Gateway to Local Adoption Series

Latest content